These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17562785)

  • 1. Effect of lercanidipine on kidney microanatomy in Cohen-Rosenthal diabetic hypertensive rats.
    Rosenthal T; Rosenmann E; Tomassoni D; Amenta F
    J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):145-52. PubMed ID: 17562785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of treatment with lercanidipine on heart of Cohen-Rosenthal diabetic hypertensive rats.
    Amenta F; Peleg E; Tomassoni D; Sabbatini M; Rosenthal T
    Hypertension; 2003 Jun; 41(6):1330-5. PubMed ID: 12719440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroprotective effect of treatment with calcium channel blockers in spontaneously hypertensive rats.
    Sabbatini M; Vitaioli L; Baldoni E; Amenta F
    J Pharmacol Exp Ther; 2000 Sep; 294(3):948-54. PubMed ID: 10945845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
    Rumble JR; Doyle AE; Cooper ME
    Am J Hypertens; 1995 Jan; 8(1):53-7. PubMed ID: 7734098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats.
    Martinez ML; Castro MM; Rizzi E; Fernandes K; Demacq C; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Sep; 591(1-3):224-30. PubMed ID: 18634778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.
    Sato T; Nara Y; Note S; Yamori Y
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S192-4. PubMed ID: 2455131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats.
    Martinez ML; Rizzi E; Castro MM; Fernandes K; Bendhack LM; Gerlach RF; Tanus-Santos JE
    Eur J Pharmacol; 2008 Dec; 599(1-3):110-6. PubMed ID: 18930722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of psychosomatic symptomatology in hypertensive patients treated with lercanidipine (LERCAPSICO study)].
    Abellán Alemán J; Martínez García JF; Merino Sánchez J; Gil Guillén V; Latorre Hernández J; Fernández Montero F; Navarro Lima A;
    An Med Interna; 2003 Jun; 20(6):287-91. PubMed ID: 12848598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats.
    Sabbatini M; Leonardi A; Testa R; Vitaioli L; Amenta F
    Hypertension; 2000 Mar; 35(3):775-9. PubMed ID: 10720594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dihydropyridine-type Ca2+ antagonists on the renal arterial tree in spontaneously hypertensive rats.
    Sabbatini M; Leonardi A; Testa R; Tomassoni D; Vitaioli L; Amenta F
    J Cardiovasc Pharmacol; 2002 Jan; 39(1):39-48. PubMed ID: 11743226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
    Meier P; Burnier M
    Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deuterium oxide normalizes blood pressure and elevated cytosolic calcium in rats with ethanol-induced hypertension.
    Vasdev S; Gupta IP; Sampson CA; Longerich L; Parai S
    Can J Cardiol; 1993 Nov; 9(9):802-8. PubMed ID: 8281480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan and lercanidipine attenuate low-density lipoprotein oxidation in patients with hypertension and type 2 diabetes mellitus: a randomized, prospective crossover study.
    Rachmani R; Levi Z; Zadok BS; Ravid M
    Clin Pharmacol Ther; 2002 Sep; 72(3):302-7. PubMed ID: 12235451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles.
    Kimura K; Tojo A; Hirata Y; Hayakawa H; Goto A; Omata M
    Blood Press Suppl; 1994; 5():71-4. PubMed ID: 7889206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lercanidipine in the treatment of hypertension.
    Beckey C; Lundy A; Lutfi N
    Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.